Clinical Trial

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if drug montelukast works to treat dengue in adults. It will also learn about the safety of drug montelukast . The main questions it aims to answer are: Does drug montelukast lower the incidence of liver enzyme elevations in participants ? What medical problems do participants have when taking drug montelukast ?
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-18; most recent amendment 2025-05-27.
Status change: Not Yet Recruiting → Recruiting 2025-05-27
Trial Details
NCT Number NCT06747130
Lead Sponsor Phramongkutklao College of Medicine and Hospital
Conditions Dengue, Montelukast, Transaminases
Enrollment 82 participants
Start Date 2025-01-31
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-29